Search

everythinglearnresearchcommunity

for

Search:↓

Slovak breast cancer survivors have moderate quality of life, with emotional and cognitive strengths but social and physical challenges, needing targeted support.

Spiritual well-being improves quality of life for Palestinian women with breast cancer.

Pranic meditation significantly improved mental health and quality of life for breast cancer survivors.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Spiritual well-being is crucial for improving quality of life in women with breast cancer.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

People undergoing chemotherapy need better support and information to cope with hair loss.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Analog 23 is a promising compound for prostate cancer treatment.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

A genetic defect causes males in some Mediterranean populations to be born with ambiguous genitalia and develop male traits at puberty.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Brg1 is crucial for hair growth and skin repair by maintaining stem cells and promoting regeneration.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Fusarium sp. strain K-23 helps Arabidopsis plants grow better in salty soil by promoting root hair growth.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.